Business · 25/04/2012Updated: 10/17/2026 · 1 min read
Sanofi-aventis Withdraws FDA Approval for OFORTA Tablets
Summary
Sanofi-aventis has voluntarily withdrawn its request for FDA approval of OFORTA (fludarabine phosphate) Tablets, waiving its opportunity for a hearing, following a voluntary request by the company.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →